Pritibha Singh

Comparison of EP2006, a filgrastim biosimilar, to the reference: a phase III, randomized, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy

Kimberly Blackwell, Vladimir Semiglazov, Dmitriy Krasnozhon et al. · Annals of Oncology · 2015 · 81 citations · Full text

Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non‐motor symptoms – results of a double‐blind, randomized, placebo‐controlled trial

Angelo Antonini, Lars Bauer, Elisabeth Dohin et al. · European Journal of Neurology · 2015 · 73 citations

Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into Practice

Bohdana Ratitch, James Bell, Craig Mallinckrodt et al. · Therapeutic Innovation & Regulatory Science · 2020 · 73 citations

Patient Selection, Clinical Endpoint, Clinical Evidence +7

Aligning Estimators With Estimands in Clinical Trials: Putting the ICH E9(R1) Guidelines Into Practice

Craig Mallinckrodt, James Bell, G. Liu et al. · Therapeutic Innovation & Regulatory Science · 2020 · 65 citations

Meta-analysis, Clinical Endpoint, Clinical Epidemiology +10

Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: Results from a six-month prospective, multinational, observational study

Tamás Treuer, Vicki Poole Hoffmann, Antony Kuang-Peng Chen et al. · The World Journal of Biological Psychiatry · 2009 · 55 citations